Catalent Inc.

N/A : CTLT
Pharmaceuticals
Somerset NJ
Revenue (US$ Millions)$1,828
Revenue Growth (%)1.52%
Net Income (Millions)$16
Common Shares Outstanding (Millions)$75
Earnings per Share$0.21
Price To Earnings RatioN/A
Total Equity (Millions)($371)
Profit Margin 10.89%
Return on Equity-88%
Long Term Debt (US$ Millions)$2,685
Debt To Equity Ratio (%)-88%
Market Capitalization (US$ Millions)N/A
Total Assets (US$ Millions)$3,090
Return on Assets (%)0.53
Current Assets (US$ Millions)$688
Inventories (US$ Millions)$135
Current Liabilities (US$ Millions)$453
Cost of Goods Sold (US$ Millions)$1,229
Asset Turnover0.59
Inventory Turnover9.47